LTR Pharma Limited (ASX: LTP)
Australia
· Delayed Price · Currency is AUD
1.225
+0.005 (0.41%)
Nov 21, 2024, 2:42 PM AEST
LTR Pharma Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -6.95 | -6.95 | -1.45 | -1.03 | -0.04 |
| Stock-Based Compensation | 1.3 | 1.3 | 0.02 | - | - |
| Other Operating Activities | 0.01 | 0.01 | 0.02 | 0.01 | - |
| Change in Accounts Receivable | 0.1 | 0.1 | -0.03 | -0.01 | -0 |
| Change in Accounts Payable | 0.44 | 0.44 | -0.09 | 0.46 | 0.01 |
| Operating Cash Flow | -5.09 | -5.09 | -1.54 | -0.57 | -0.03 |
| Capital Expenditures | -0 | -0 | -0 | - | - |
| Investing Cash Flow | -0 | -0 | -0 | - | - |
| Short-Term Debt Issued | - | - | - | - | 0.35 |
| Total Debt Issued | - | - | - | - | 0.35 |
| Net Debt Issued (Repaid) | - | - | - | - | 0.35 |
| Issuance of Common Stock | 7 | 7 | 1.45 | 2.34 | 0.1 |
| Other Financing Activities | -0.5 | -0.5 | -0.07 | - | -0.27 |
| Financing Cash Flow | 6.5 | 6.5 | 1.38 | 2.34 | 0.18 |
| Foreign Exchange Rate Adjustments | -0.03 | -0.03 | -0.02 | -0.01 | -0 |
| Net Cash Flow | 1.37 | 1.37 | -0.18 | 1.76 | 0.15 |
| Free Cash Flow | -5.09 | -5.09 | -1.54 | -0.57 | -0.03 |
| Free Cash Flow Margin | -10396.58% | -10396.58% | - | -6258.86% | - |
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.01 | - | - |
| Cash Interest Paid | 0 | 0 | 0 | 0 | - |
| Cash Income Tax Paid | - | - | - | -0.01 | - |
| Levered Free Cash Flow | -2.83 | -2.83 | -1.35 | -0.31 | - |
| Unlevered Free Cash Flow | -2.83 | -2.83 | -1.35 | -0.31 | - |
| Change in Net Working Capital | -0.21 | -0.21 | 0.48 | -0.33 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.